Silexion TherapeuticsOrdinary Shares share price logo

Silexion TherapeuticsOrdinary Shares

NASDAQ: SLXN

Small Cap

$2.71

-0.04

(-1.45%)

as on

Silexion TherapeuticsOrdinary Shares Stock Performance

as on June 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.33
    $2.77
    downward going graph

    14.02%

    Downside

    2.21%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.31
    $223.60
    downward going graph

    14.76%

    Downside

    8150.92%

    Upside

    downward going graph

Silexion TherapeuticsOrdinary Shares share price movements today

Previous Close
$2.75
Open
$2.52
Volume
389.7K
Day's Low - High
$2.33 - $2.77
52 Week Low - High
$2.31 - $223.60

Silexion TherapeuticsOrdinary Shares Historical Returns

1 Month Return
-6.23 %
3 Month Return
-82.63 %
1 Year Return
-97.76 %
3 Year Return
0 %
5 Year Return
0 %

Silexion TherapeuticsOrdinary Shares Stock Fundamentals & Key Indicators

Check Silexion TherapeuticsOrdinary Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.9M

EPS (TTM)

-41.2

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-897.46%

Silexion TherapeuticsOrdinary Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Silexion TherapeuticsOrdinary Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Silexion TherapeuticsOrdinary Shares image
Silexion TherapeuticsOrdinary Shares
NA$2.9MNANA0.00%NA
Alnylam Pharmaceuticals Common Stock image
Alnylam Pharmaceuticals Common Stock
BUY$38.4B63.66%72.4912.55%NA
Vertex PharmaceuticalsCommon Stock image
Vertex PharmaceuticalsCommon Stock
BUY$114.3B140.59%26.7335.51%NA
Regeneron Pharmaceuticals Common Stock image
Regeneron Pharmaceuticals Common Stock
BUY$64.5B14.69%15.0229.65%0.58%

Stock Returns calculator for Silexion TherapeuticsOrdinary Shares Stock including INR - Dollar returns

The Silexion TherapeuticsOrdinary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Silexion TherapeuticsOrdinary Shares investment value today

Current value as on today

₹2,455

Returns

-₹97,545

(-97.55%)

Returns from Silexion TherapeuticsOrdinary Shares Stock

-₹97,758 (-97.76%)

Dollar Impact

₹213 (+0.21%)

Indian Investors' Interest in Silexion TherapeuticsOrdinary Shares Stock

Search interest for Silexion TherapeuticsOrdinary Shares Stock has increased by 3907% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:3907% versus previous 30 day period

Silexion TherapeuticsOrdinary Shares Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
0
0
-
0
0
0
0
0
Operating Income
-1
-1
-1
-8
-1
-1
-2
-3
18
-2
EBITDA
-1
-1
-1
-11
-1
-1
-2
-3
-4
-2
Interest Expense
0
-
0
0
-
0
-
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-1
-1
-11
-1
-1
-2
-3
-4
-2
Income Tax Expense
0
0
0
0
0
-
0
-
-
-
Net Income
-1
-1
-1
-11
-1
-1
-2
-3
-4
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Silexion TherapeuticsOrdinary Shares Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
Gross Profit
-
-
0
0
Operating Income
-3
-4
-12
11
EBITDA
-3
-5
-16
-11
Interest Expense
0
0
0
0
Depreciation
0
0
0
0
Income Before Tax
-3
-5
-16
-11
Income Tax Expense
0
0
0
0
Net Income
-3
-4
-16
-11
Net Profit Margin
0.00%
0.00%
0.00%
0.00%

Silexion TherapeuticsOrdinary Shares Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1
-1
-11
-1
-1
-2
-3
-4
-2
Operating Cash Flow
-1
-1
-2
-2
-2
-2
-2
-3
-3
Investing Cash Flow
0
-
0
-
0
0
-
0
-
Financing Cash Flow
-
-
2
2
7
0
8
0
0
Change in Cash
-1
-1
0
0
4
-2
5
-3
-3

Silexion TherapeuticsOrdinary Shares Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
-3
-5
-16
-11
Operating Cash Flow
0
-1
-3
-4
-8
-10
Investing Cash Flow
-
-
0
0
0
0
Financing Cash Flow
0
116
2
0
5
15
Change in Cash
0
0
-1
-3
-3
4

Global Institutional Holdings in Silexion TherapeuticsOrdinary Shares

Funds
Holdings
TWO SIGMA SECURITIES, LLC
0.28%
A. Montag & Associates Inc
0.07%
UBS Group AG
0.01%
Pflug Koory, LLC.
0.01%
JONES FINANCIAL COMPANIES LLLP
0%
See all

Insights on Silexion TherapeuticsOrdinary Shares

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 20.8% return, outperforming this stock by 118.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SLXN stock has moved down by -11.4%

About Silexion TherapeuticsOrdinary Shares

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
OrganisationSilexion TherapeuticsOrdinary Shares
HeadquartersThe Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001
IndustryBiotechnology
CEOMr. Ilan Hadar M.B.A.
E-voting on sharesClick here to vote

Key Management of Silexion TherapeuticsOrdinary Shares

Name

Title

Mr. Ilan Hadar M.B.A.

Chairman & CEO

Ms. Mirit Horenshtein Hadar

EVP of Finance Affairs, CFO & Secretary

Dr. Mitchell Shirvan M.B.A., Ph.D.

Chief Scientific & Development Officer

FAQs

What is Silexion TherapeuticsOrdinary Shares share price today?

Silexion TherapeuticsOrdinary Shares share price today is $2.71 as on at the close of the market. Silexion TherapeuticsOrdinary Shares share today touched a day high of $2.77 and a low of $2.33.

What is the 52 week high and 52 week low for Silexion TherapeuticsOrdinary Shares share?

Silexion TherapeuticsOrdinary Shares share touched a 52 week high of $223.6 on and a 52 week low of $2.31 on . Silexion TherapeuticsOrdinary Shares stock price today i.e. is closed at $2.71,which is 98.79% down from its 52 week high and 17.32% up from its 52 week low.

What is Silexion TherapeuticsOrdinary Shares's market capitalisation today?

Silexion TherapeuticsOrdinary Shares market capitalisation is $0.00T as on .

How to invest in Silexion TherapeuticsOrdinary Shares Stock (SLXN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Silexion TherapeuticsOrdinary Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Silexion TherapeuticsOrdinary Shares Shares that will get you 0.5535 shares as per Silexion TherapeuticsOrdinary Shares share price of $2.71 per share as on June 17, 2026 at 8:46 am IST.

What is the minimum amount required to buy Silexion TherapeuticsOrdinary Shares Stock (SLXN) from India?

Indian investors can start investing in Silexion TherapeuticsOrdinary Shares (SLXN) shares with as little as ₹94.5 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹945.00 in Silexion TherapeuticsOrdinary Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on Silexion TherapeuticsOrdinary Shares share’s latest price of $2.71 as on June 17, 2026 at 8:46 am IST, you will get 3.6900 shares of Silexion TherapeuticsOrdinary Shares. Learn more about fractional shares .